Dr. Salma Jabbour, MD
Claim this profileEmory University
Studies Lung Cancer
Studies Skin Cancer
5 reported clinical trials
10 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage IV
Stage II
2Skin Cancer
Stage III
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Salma Jabbour, MD is currently running
Pembrolizumab + Capecitabine + Radiation
for Gastric Cancer
This phase II trial studies how well pembrolizumab works with capecitabine and radiation therapy in treating patients with mismatch repair deficient and Epstein-Barr virus positive gastric cancer. Monoclonal antibodies, such as pembrolizumab may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such as capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving pembrolizumab, capecitabine and radiation therapy may work better at treating gastric cancer.
Recruiting1 award Phase 2
Tislelizumab
for Liver Cancer
The investigators hypothesize that the addition of Tislelizumab after definitive local therapy for locally advanced inoperable Hepatocellular carcinoma (HCC) will synergize with local therapy as well as treat micro metastatic disease and improve one year progression-free survival rates for participants and optimize local control.
Recruiting1 award Phase 2
More about Salma Jabbour, MD
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Salma Jabbour, MD has experience with
- Pembrolizumab
- AN0025
- Capecitabine
- Radiation Therapy
- Radiation Treatment
- 3-Dimensional Conformal Radiation Therapy
Breakdown of trials Salma Jabbour, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Epstein-Barr Virus Infection
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Salma Jabbour, MD specialize in?
Salma Jabbour, MD focuses on Lung Cancer and Skin Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Salma Jabbour, MD currently recruiting for clinical trials?
Yes, Salma Jabbour, MD is currently recruiting for 3 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Salma Jabbour, MD has studied deeply?
Yes, Salma Jabbour, MD has studied treatments such as Pembrolizumab, AN0025, Capecitabine.
What is the best way to schedule an appointment with Salma Jabbour, MD?
Apply for one of the trials that Salma Jabbour, MD is conducting.
What is the office address of Salma Jabbour, MD?
The office of Salma Jabbour, MD is located at: Emory University, Atlanta, Georgia 30322 United States. This is the address for their practice at the Emory University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.